Bronstein, Gewirtz & Grossman LLC Urges Alexandria Real Estate Equities, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Alexandria Real Estate Equities, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Alexandria Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces […]

Bronstein, Gewirtz & Grossman LLC Urges StubHub Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges StubHub Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges StubHub Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Mortgage Rates Stable, Purchase Demand Rising

Mortgage Rates Stable, Purchase Demand Rising GlobeNewswire January 08, 2026 MCLEAN, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey(R) (PMMS(R)), showing the 30-year fixed-rate mortgage (FRM) averaged 6.16%. “In the first full week of the new year, mortgage rates remained within a

MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease

MiNK Therapeutics and University of Wisconsin-Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease GlobeNewswire January 08, 2026 Non-dilutive public-private funded trial with NIAID STTR & Mary Gooze Clinical Trial and Translation Award Expands iNKT platform into transplantation with an off-the-shelf, HLA-independent, lymphodepletion-free experimental therapy in patients

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Charming Medical Ltd. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Charming Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Bronstein, Gewirtz & Grossman LLC Urges Firefly Aerospace Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Firefly Aerospace Inc. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Firefly Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Bronstein, Gewirtz & Grossman LLC Urges Bitdeer Technologies Group Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Bitdeer Technologies Group Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Bitdeer Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Bronstein, Gewirtz & Grossman LLC Urges Genius Group Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Genius Group Limited Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges GNUS Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK-, Jan. 08, 2026 (GLOBE NEWSWIRE) — Attorney Advertising–Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Quantum Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm Nationally Recognized Firm Urges Telix Investors to Explore Class Action Representation GlobeNewswire January 08, 2026 NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a

Scroll to Top